Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
2025 · 3rd Quarter (July 1 - Sep 30)
ACCENDRA HEALTH INC.
Filed by ACCENDRA HEALTH INC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 16, 2025
- Income
- Not reported
- Expenses
- $190,000.00
- Registrant
- ACCENDRA HEALTH INC.
- Client
- ACCENDRA HEALTH INC.
- Filing UUID
- 4f76a46d-6445-42d6-8c18-650df84b4d0a
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to competitive bidding for home medical equipment; patient access to home respiratory services including oxygen therapy and related reimbursement (i.e., the Supplemental Oxygen Access Reform ["SOAR"] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
FY 2026 Appropriations.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.